Health insurance benefits on 125 products containing Huahai’s Valsartan temporarily suspended

Published: 2018-07-11 17:45:32

Updated: 2018-07-11 17:45:32

The health insurance benefits for 125 antihypertensive products which use Chinse ‘Valsartan’ have been suspended.

The Ministry of Health and Welfare(MOHW) Pharmaceutical Benefits Division informed the ‘Notification Alerts for Suspension of Health Insurance Benefits’ on the 9^th.

Previously, the Ministry of Food and Drug Safety informed that sales and use of Korean finished drugs containing Val...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.